Top Markets
Coin of the day
TCM Biotech International Corp. TCM Biotech International Corp.

TCM Biotech International Corp.

4169
Classement en actions #15799
TCM Biotech International Corp., a biotech company, engages in the research and... TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Prix de l'action
$4.96
Capitalisation boursière
$329.54M
Changement (1 jour)
2.63%
Changement (1 an)
53.49%
Pays
TW
Échange TCM Biotech International Corp. (4169)

Catégorie

Ratio P/B pour TCM Biotech International Corp. (4169)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de TCM Biotech International Corp., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour TCM Biotech International Corp. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH